United Therapeutics | UTHR - Ebitda

Stock Price
536.12
Daily Change
3.30 0.62%
Monthly
11.13%
Yearly
74.50%
Q1 Forecast
519.93

United Therapeutics reported $379.5M in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Amarin USD 12.54M 28.57M Jun/2025
Ardelyx USD 5.57M 17.44M Sep/2025
Baxter International USD 426M 36M Sep/2025
Bayer EUR 1.97B 457M Dec/2025
Biogen USD 573.2M 253.7M Dec/2025
BioMarin Pharmaceutical USD -24.17M 18.91M Dec/2025
Esperion Therapeutics USD -27.51M 9.5M Sep/2023
Gilead Sciences USD 4.03B 628M Sep/2025
GlaxoSmithKline GBP 3.36B 179M Sep/2025
Halozyme Therapeutics USD 21.9M 226.34M Dec/2025
Insmed USD -314.19M 31.48M Dec/2025
Ionis Pharmaceuticals USD -157.12M 307.36M Sep/2025
J&J USD 9.52B 389M Sep/2025
Moderna USD -790M 582M Dec/2025
Omeros USD -47.96M 7.39M Sep/2023
Pfizer USD 6.08B 351M Sep/2025
PTC Therapeutics USD 20.63M 53.74M Sep/2025
Regeneron Pharmaceuticals USD 1.92B 261.9M Sep/2025
Sarepta Therapeutics USD -168.03M 294.45M Sep/2025
Teva Pharmaceutical Industries USD 1.64B 243M Dec/2025
United Therapeutics USD 379.5M 83.4M Dec/2025
Vertex Pharmaceuticals USD 1.44B 100.4M Sep/2025